MedTrace Logo

Holmium-166 Retrospective Collection of Real-World Data

NCT05111795 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 146

Last updated 2022-08-30

No results posted yet for this study

Summary

The primary objective of the study is to further describe the general safety and clinical performance of QuiremSpheresTM Holmium-166 Microspheres and QuiremScoutTM Holmium-166 Microspheres in a real-world post-market setting, with specific attention to outcomes per tumor origin.

Conditions

Interventions

DEVICE

Selective Internal Radiation Therapy with QuiremSpheresTM Holmium-166 Microspheres

SIRT work-up procedure and SIRT procedure

Sponsors & Collaborators

  • Terumo Europe N.V.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-17
Primary Completion
2022-02-15
Completion
2022-04-08

Countries

  • Belgium
  • Germany
  • Italy
  • Netherlands
  • Portugal
  • Spain
  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05111795 on ClinicalTrials.gov